InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Tuesday, 04/15/2014 8:41:06 AM

Tuesday, April 15, 2014 8:41:06 AM

Post# of 8553
Citigroup initiates coverage on Halozyme Therapeutics, Inc. (NASDAQ: HALO) with a Buy rating and a $12.00 price target.

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News